Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

Por Abdul Razak, Albiruni Ryan, Li, Louise, Bryant, Andrew, Diaz-Padilla, Ivan
Publicado em 2011

Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer

Por Castonguay, Vincent, Wilson, Michelle K., Diaz‐Padilla, Ivan, Wang, Lisa, Oza, Amit M.
Publicado no Cancer (2014)

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment

Por Patrono, María Guadalupe, Minig, Lucas, Diaz-Padilla, Ivan, Romero, Nuria, Rodriguez Moreno, Juan Francisco, Garcia-Donas, Jesus
Publicado em 2013

Fatal respiratory disease due to a homozygous intronic ABCA3 mutation: a case report

Por Pachajoa, Harry, Ruiz-Botero, Felipe, Meza-Escobar, Luis Enrique, Villota-Delgado, Vania Alexandra, Ballesteros, Adriana, Padilla, Ivan, Duarte, Diana
Publicado no J Med Case Rep (2016)

Alcohol and tobacco consumption concordance and its correlates in older couples in Latin America

Por Machado, Mayra Pires Alves, Opaleye, Davi Camara, Pereira, Tiago Veiga, Padilla, Ivan, Noto, Ana Regina, Prince, Martin, Ferri, Cleusa Pinheiro
Publicado no Geriatr Gerontol Int (2017)

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

Por Chiu, Joanne W., Hotte, Sebastien J., Kollmannsberger, Christian K., Renouf, Daniel J., Cescon, David W., Hedley, David, Chow, Sue, Moscow, Jeffrey, Chen, Zhuo, Perry, Meghan, Diaz-Padilla, Ivan, Tan, David, Hirte, Hal, McWhirter, Elaine, Chen, Helen, Siu, Lillian L., Bedard, Philippe L.
Publicado no Invest New Drugs (2015)

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

Por Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Publicado em 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Por Mayer, Ingrid A., Prat, Aleix, Egle, Daniel, Blau, Sibel, Perez Fidalgo, J. Alejandro, Gnant, Michael, Fasching, Peter A., Colleoni, Marco, Wolff, Antonio C., Winer, Eric P., Singer, Christian F., Hurvitz, Sara, Estevez, Laura Garcia, van Dam, Peter A., Kümmel, Sherko, Mundhenke, Christoph, Holmes, Frankie, Babbar, Naveen, Charbonnier, Laure, Diaz-Padilla, Ivan, Vogl, Florian D., Sellami, Dalila, Arteaga, Carlos L.
Publicado no Clin Cancer Res (2019)

Ovarian Cancer

Publicado em 2013